B-Cell Lymphoma Immunotherapy Using TLR9-targeted Oligonucleotide STAT3 Inhibitors
Molecular Therapy - United States
doi 10.1016/j.ymthe.2018.01.007
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Elsevier BV
Available in full text
March 1, 2018
Elsevier BV